Genemod Raises $4.5M to Expand Central Research Platform for Biopharma Companies

Genemod Raises .5M to Expand Central Research Platform for Biopharma Companies
Genemod Raises .5M to Expand Central Research Platform for Biopharma Companies


Genemod Raises $4.5M to Expand Central Research Platform for Biopharma Companies

What You Should Know:

  • Genemoda cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partnerswith participation from Dolby Family Ventures and Vulcan/Cercano Ventures.
  • Genemod digitizes data capture and workflows, so scientists can collaborate easily across an organization to accelerate life sciences R&D.

Digitize Research Workflows in Minutes

Legacy R&D software and other traditional methods are decentralized, disorganized and inefficient, ultimately resulting in higher healthcare costs. Genemod is working to be the solution to this problem by building a dynamic cloud-based research platform designed for research teams to house their entire R&D lifecycle: from data acquisition and project documentation to inventory management and reporting. The intuitive interface allows users to easily visualize their data and track progress and updates – including what changes are made by whom.

In the past year, Genemod has expanded into the biopharma R&D space working with teams from startups to enterprise companies including AstraZeneca, Bristol-Myers, Merck, and more. Working across siloed spreadsheets, updating data in real time and collaborating on projects in disparate geographical locations are just a few examples of how teams using Genemod are able to eliminate busywork and other barriers so they can focus on developments in biopharma.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *